Gilead Sciences (GILD) Tops Q3 EPS by 21c, Offers Guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $65.27 -2.7%
EPS Growth %: -343.8%
Financial Fact:
Selling, general and administrative: 831M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -343.8%
Financial Fact:
Selling, general and administrative: 831M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $1.84, $0.21 better than the analyst estimate of $1.63. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.38 billion.
GUIDANCE:
Gilead Sciences sees Q4 2018 revenue of $20.8-21.3 billion, versus the consensus of $21.43 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
- L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
